Aura Biosciences (AURA) Earnings Analysis
Aura Biosciences (AURA) next reports earnings on 2026-08-12, consensus EPS -0.41 USD. Last quarter (2026-05-11) it missed with EPS -0.5 USD vs -0.4 USD est (-25%). It has beaten estimates in 4/7 recent quarters (57%). Trailing P/E -3.96.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does AURA next report earnings?
| Next earnings date | 2026-08-12 |
|---|---|
| Consensus EPS estimate | -0.41 USD |
| Revenue estimate | n/a |
AURA earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-11 | -0.5 USD | -0.4 USD | -25% | Miss |
| 2026-03-30 | -0.37 USD | -0.43 USD | +14% | Beat |
| 2025-11-13 | -0.4 USD | -0.46 USD | +13% | Beat |
| 2025-08-13 | -0.47 USD | -0.49 USD | +4.1% | Beat |
| 2025-05-15 | -0.55 USD | -0.47 USD | -17% | Miss |
| 2025-03-24 | -0.52 USD | -0.43 USD | -20.9% | Miss |
| 2024-08-08 | -0.41 USD | -0.45 USD | +8.9% | Beat |
Beat rate: 4/7 (57%) over reported quarters with consensus data.
AURA valuation and analyst view
| Trailing P/E | -3.96 |
|---|---|
| Trailing EPS | -1.66638 USD |
| Price / book | 4.41 |
| Dividend yield | 0.00% |
| Market cap | 0.45B |
| Analyst consensus | Buy (8 buy / 0 hold / 0 sell) |
| Avg price target | 17 USD |
Related research pages
Frequently asked questions
When is Aura Biosciences (AURA)'s next earnings date?
Aura Biosciences is next scheduled to report on 2026-08-12, with a consensus EPS estimate of -0.41 USD.
Did AURA beat earnings last quarter?
In its 2026-05-11 report, AURA posted EPS of -0.5 USD versus a -0.4 USD estimate — a miss of 25%.
What is AURA's earnings track record?
Over the last 7 reported quarters with consensus data, AURA beat estimates 4 times (57%).
What is AURA's current P/E ratio and EPS?
AURA trades at a trailing P/E of -3.96 on trailing EPS of -1.666375675235534 USD.
What do analysts rate AURA?
Analyst consensus is "Buy" across 8 ratings (0 strong buy, 8 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 17 USD.